Curis, Inc.
General ticker "CRIS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $22.8M (TTM average)
Curis, Inc. does not follow the US Stock Market performance with the rate: -30.1%.
Estimated limits based on current volatility of 4.0%: low 0.51$, high 0.55$
Factors to consider:
- Total employees count: 49 as of 2023
- Top business risk factors: Insufficient funding, Labor/talent shortage/retention, Expansion risks, Intellectual property risks, Litigation risks
- Current price 23.5% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.65$, 2.19$]
- 2026-12-31 to 2027-12-31 estimated range: [0.64$, 2.10$]
Financial Metrics affecting the CRIS estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 1.79 > -0.60
- Positive: Interest expense per share per price, % of 1.56 <= 3.31
- Positive: 19.24 < Shareholder equity ratio, % of 27.36 <= 42.59
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term CRIS quotes
Long-term CRIS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $10.02MM | $10.91MM | $9.44MM |
| Operating Expenses | $58.35MM | $55.45MM | $42.34MM |
| Operating Income | $-48.33MM | $-44.54MM | $-32.90MM |
| Non-Operating Income | $0.92MM | $1.15MM | $25.32MM |
| Interest Expense | $2.02MM | $0.61MM | $2.19MM |
| R&D Expense | $39.50MM | $38.56MM | $28.25MM |
| Income(Loss) | $-47.41MM | $-43.39MM | $-7.58MM |
| Net Income(Loss)* | $-47.41MM | $-43.39MM | $-7.58MM |
| Stockholders Equity | $19.67MM | $-6.00MM | $5.46MM |
| Assets | $77.28MM | $41.27MM | $19.97MM |
| Operating Cash Flow | $-38.43MM | $-39.56MM | $-27.20MM |
| Investing Cash Flow | $37.79MM | $29.44MM | $2.50MM |
| Financing Cash Flow | $7.58MM | $3.44MM | $9.77MM |
| Earnings Per Share** | $-8.96 | $-6.88 | $-0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.